gut microbiota metagenome sequencing for NSCLC patients received anti-PD-1 treatment
收藏NIAID Data Ecosystem2026-05-10 收录
官方服务：
资源简介：
Study goal: determine the gut bacterial species that were most prevalent and enriched in responders
应用场景：
创建时间：
2026-01-01
相关数据集
Bioinformatic Methods and Bridging of Assay Results for Reliable Tumor Mutational Burden Assessment in Non-Small Cell Lung Cancer
Tumor mutational burden (TMB) has emerged as a predictive biomarker of response to immune checkpoint inhibitors. Standardization of TMB measurement is essential for implementing diagnostic tools to gu
NIAID Data Ecosystem70
DataSheet_1_ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer.docx
Worldwide, non-small cell lung cancer (NSCLC) has the highest morbidity and mortality of all malignancies. The lack of responsiveness to checkpoint inhibitors is a central problem in the modern era of
NIAID Data Ecosystem30
Table_1_Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer.XLSX
Background: We hypothesized that non-small cell lung cancer (NSCLC) patients with a tumor positive for single nucleotide polymorphisms (SNPs) of the Excision Repair Cross Complementation Group 1 (ERCC
NIAID Data Ecosystem10
Gut microbiome of melanoma patients with a complete response to immunotherapy
Metastatic melanoma patients with a late complete response to immunotherapy exhibit different microbiome and dietary habits compared to early responders
NIAID Data Ecosystem30
Metagenomic shotgun sequencing of gut microbiomes of melanoma patients receiving immune checkpoint inhibitor therapy. human gut metagenome
Metagenomic shotgun sequencing identifies specific human gut microbes that are associated with immune checkpoint therapy efficacy in melanoma patients
NIAID Data Ecosystem20
